Clinical Trial Update: Combination of Radiation Therapy and Peptide Specific CTL Therapy in Treating Patients With Esophageal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating combining radiation therapy with peptide-specific cytotoxic T-lymphocyte therapy for esophageal neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Neoplasms

Drugs mentioned

• Peptide Specific CTL Therapy

Snippet

Sponsor: Shixiu Wu | Conditions: Esophageal Neoplasms, Esophageal Diseases | Phase 2 | Status: UNKNOWN